Test Results
Ordered by Dr. Sung
Collected July 23, 2015
|
Flags
|
Results
|
Reference Range
|
Units
|
|---|
| Hematology | |||||
|---|---|---|---|---|---|
|
WBC
|
6.7
|
4.0-10.0
|
giga/L
|
||
|
RBC
|
4.59
|
3.80-4.80
|
tera/L
|
||
|
Hemoglobin
|
131
|
120-150
|
g/L
|
||
|
Hematocrit
|
0.38
|
0.35-0.43
|
|||
|
MCV
|
84
|
82-98
|
fl
|
||
|
MCH
|
28.5
|
27.5-33.5
|
pg
|
||
|
MCHC
|
341
|
305-365
|
g/L
|
||
|
RDW
|
13.7
|
11.5-14.5
|
%
|
||
|
Platelet Count
|
257
|
150-400
|
giga/L
|
||
| Differential | |||||
|
Neutrophils
|
4.5
|
2.0-7.5
|
giga/L
|
||
|
Lymphocytes
|
1.7
|
1.0-4.0
|
giga/L
|
||
|
Monocytes
|
0.4
|
0.1-0.8
|
giga/L
|
||
|
Eosinophils
|
0.1
|
0.0-0.7
|
giga/L
|
||
|
Basophils
|
0.0
|
0.0-0.2
|
giga/L
|
||
|
Granulocytes Immature
|
0.0
|
<0.2
|
giga/L
|
||
| Biochemical Investigation of Anemias and Iron Overload | |||||
|
Ferritin
|
20
|
15-180
|
ug/L
|
||
|
Adults: <15: diagnostic of Iron Deficiency Children: <12: diagnosis of Iron Deficiency |
|||||
| General Chemistry | |||||
|
Creatinine
|
55
|
50-100
|
umol/L
|
||
|
Estimated GFR
|
117
|
>=60
|
mL/min
|
||
|
As of December 15, 2014, eGFR will be Kidney function estimate based on |
|||||
|
Alanine Aminotransferase
|
18
|
<50
|
U/L
|
||
| Serum Proteins | |||||
|
C Reactive Protein (High Sensitivity)
|
A
|
7.2
|
<5.0
|
mg/L
|
|
| High-sensitivity method suitable for cardiovascular risk assessment. |
|||||
| Immunology | |||||
| DNA Double Strand Ab | |||||
|
DNA Double Strand Ab
|
4
|
<=4
|
IU/mL
|
||
| NEGATIVE 30% of SLE patients do not have antibodies to dsDNA. Antibodies to native dsDNA are found in 60% of patients with SLE, and are highly specific for this condition. The antibody titre fluctuates with SLE disease activity (especially renal disease.) New method as of April 28, 2014. Tested by a multiplex flow immunoassay (BioPlex) method. |
|||||
| Blood Culture | |||||
| Right Arm – Specimen #1 |
|||||
| Comment | REMOVED | ||||
| Report Status | Final | ||||
| Organism 1 | 1) NO GROWTH AFTER 5 DAYS | ||||
| Left Arm – Specimen #2 |
|||||
| Comment | REMOVED | ||||
| Report Status | Final | ||||
| Organism 1 | 1) NO GROWTH AFTER 5 DAYS | ||||
| Referred Tests | |||||
| Cryptococcal Serology | |||||
| Cryptococcal Serology Sent to BC Centre for Disease Control (Prov Lab). Physicians may call 1-877-747-2522 (1-877-PHSALAB) for results. |
|||||
| ECG | |||||
| Electrocardiogram Forwarded to the Cardiologist Interpretation will be sent directly to the ordering physician within three to five business days. |
|||||
Ordered by Dr. Anthony Taylor
Collected July 30, 2015
|
Flags
|
Results
|
Reference Range
|
Units
|
|---|
| Hematology | |||||
|---|---|---|---|---|---|
|
WBC
|
7.9
|
4.0-11.0
|
x10*9/L
|
||
|
RBC
|
4.77
|
3.50-5.00
|
x10*12/L
|
||
|
Hemoglobin
|
134
|
115-160
|
g/L
|
||
|
Hematocrit
|
0.40
|
0.35-0.47
|
L/L
|
||
|
MCV
|
85
|
80-100
|
fL
|
||
|
Platelet Count
|
274
|
150-400
|
x10*9/L
|
||
| Differential | |||||
|
Neutrophils
|
4.9
|
2.0-8.0
|
x10*9/L
|
||
|
Lymphocytes
|
2.3
|
1.0-4.0
|
x10*9/L
|
||
|
Monocytes
|
0.5
|
0.1-0.8
|
x10*9/L
|
||
|
Eosinophils
|
0.2
|
<0.6
|
x10*9/L
|
||
|
Basophils
|
< 0.1
|
<0.2
|
x10*9/L
|
||
| Coagulation Studies | |||||
|
INR
|
1.1
|
0.8-1.2
|
|||
| INR Therapeutic Ranges: Mechanical Heart Valves 2.5 – 3.5 Other indications 2.0 – 3.0 |
|||||
| General Chemistry | |||||
|
Glucose Random
|
6.0
|
3.6-7.8
|
mmol/L
|
||
|
Sodium
|
141
|
135-145
|
mmol/L
|
||
|
Potassium
|
3.8
|
3.5-5.0
|
mmol/L
|
||
|
Chloride
|
104
|
98-108
|
mmol/L
|
||
|
Bicarbonate
|
26
|
20-30
|
mmol/L
|
||
|
Anion Gap
|
11
|
3-16
|
mmol/L
|
||
|
Serum Osmolality
|
H
|
297
|
275-295
|
mosm/kg
|
|
|
Osmolar Gap ETOH Corrected
|
4
|
<10
|
mosm/kg
|
||
| Osmo Gap (-ETOH) is the measured osmolality minus the calculated osmolalities of the electrolytes, glucose, urea AND the ethanol. |
|||||
|
Urea
|
5
|
2-9
|
mmol/L
|
||
|
Creatinine
|
72
|
45-90
|
umol/L
|
||
|
Estimated GFR
|
94
|
>60
|
mL/min
|
||
|
Total Protein
|
69
|
55-80
|
g/L
|
||
|
Albumin
|
40
|
35-50
|
g/L
|
||
|
Total Bilirubin
|
10
|
2-17
|
umol/L
|
||
|
Alkaline Phosphatase
|
82
|
35-105
|
U/L
|
||
|
Gamma GT
|
12
|
<31
|
U/L
|
||
|
Alanine Aminotransferase
|
28
|
<36
|
U/L
|
||
|
Aspartate Aminotransferase
|
33
|
<36
|
U/L
|
||
| Cardiac Investigation | |||||
|
Troponin I
|
< 0.04
|
<0.06
|
ug/L
|
||
| Note: New reagent formulation in use, effective Dec. 1, 2014. Results may be lower than previous results. Do not compare results from before and after effective date. No measurable Troponin present. |
|||||
| Therapeutic Drugs | |||||
|
Salicylate
|
< 0.3
|
<2.0
|
mmol/L
|
||
|
Acetaminophen
|
< 66
|
<130
|
umol/L
|
||
|
Therapeutic range 70-130 umol/L. For Suspected Overdose: use NOMOGRAM for interpretation Patients with poor nutrition and chronic heavy acetaminophen |
|||||
| Blood/Serum Drug Screen | |||||
|
Ethanol
|
< 2.0
|
<2.0
|
mmol/L
|
||
Ordered by Dr. Matthew Burnard
Collected July 31, 2015
| Microbiology | |||||
|---|---|---|---|---|---|
| Screen for MRSA | |||||
| Specimen Source | Groin – bilateral | ||||
| Culture | 1) No Methicillin Resistant Staphylococcus aureus (MRSA) isolated. | ||||
| Microbiology | |||||
|---|---|---|---|---|---|
| Screen for MRSA | |||||
| Specimen Source | Nares – bilateral | ||||
| Culture | 1) No Methicillin Resistant Staphylococcus aureus (MRSA) isolated. | ||||
Ordered by Dr. Emily Sung
Collected August 7, 2015
| Serum Proteins | |||||
|---|---|---|---|---|---|
|
C Reactive Protein (High Sensitivity)
|
A
|
7.4
|
<5.0
|
mg/L
|
|
| High-sensitivity method suitable for cardiovascular risk assessment. |
|||||
Ordered by Dr. Emily Sung
Collected October 10, 2015
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Hematology | |||||
|---|---|---|---|---|---|
|
WBC
|
5.9
|
4.0-10.0
|
giga/L
|
||
|
RBC
|
4.77
|
3.80-4.80
|
tera/L
|
||
|
Hemoglobin
|
136
|
120-150
|
g/L
|
||
|
Hematocrit
|
0.40
|
0.35-0.43
|
|||
|
MCV
|
84
|
82-98
|
fl
|
||
|
MCH
|
28.5
|
27.5-33.5
|
pg
|
||
|
MCHC
|
340
|
305-365
|
g/L
|
||
|
RDW
|
13.7
|
11.5-14.5
|
%
|
||
|
Platelet Count
|
285
|
150-400
|
giga/L
|
||
| Differential | |||||
|
Neutrophils
|
3.3
|
2.0-7.5
|
giga/L
|
||
|
Lymphocytes
|
1.9
|
1.0-4.0
|
giga/L
|
||
|
Monocytes
|
0.5
|
0.1-0.8
|
giga/L
|
||
|
Eosinophils
|
0.1
|
0.0-0.7
|
giga/L
|
||
|
Basophils
|
0.0
|
0.0-0.2
|
giga/L
|
||
|
Granulocytes Immature
|
0.0
|
<0.2
|
giga/L
|
||
|
RBC Morphology
|
RBC MORPHOLOGY essentially normal
PLATELETS normal |
||||
| Hemoglobinopathy/Thalassemia Investigation | |||||
| Hemoglobin Investigation | |||||
|
Hemoglobin A2/Total Hemoglobin
|
2.7
|
2.0-3.5
|
%
|
||
|
Hemoglobin F/Total Hemoglobin
|
0.2
|
<2.0
|
%
|
||
|
Hemoglobin Fractionation HPLC
|
Reviewed by Dr. S. Reddy
High performance liquid chromatography analysis of hemoglobin is normal. There is no evidence of beta thalassemia trait or hemoglobinopathy such as Hb S, Hb D, Hb E or Hb C. |
||||
| Biochemical Investigation of Anemias and Iron Overload | |||||
|
Vitamin B12
|
601
|
150-650
|
pmol/L
|
||
|
Ferritin
|
18
|
15-180
|
ug/L
|
||
|
Adults: <15: diagnostic of Iron Deficiency Children: <12: diagnosis of Iron Deficiency |
|||||
| Serum Proteins | |||||
|
C Reactive Protein (High Sensitivity)
|
4.1
|
<5.0
|
mg/L
|
||
| High-sensitivity method suitable for cardiovascular risk assessment. |
|||||
| Referred Tests | |||||
| Rocky Mountain Spotted Fever | |||||
| Rocky Mountain Spotted Fever Sent to BC Centre for Disease Control (Prov Lab). Physicians may call 1-877-747-2522 (1-877-PHSALAB) for results. |
|||||
| Rochalimaea | |||||
| Rochalimaea Sent to BC Centre for Disease Control (Prov Lab). Physicians may call 1-877-747-2522 (1-877-PHSALAB) for results. |
|||||
Ordered by Dr. Emily Sung
Collected October 13, 2015
| Referred Tests | |||||
|---|---|---|---|---|---|
| Lyme Disease by Western Blot | |||||
| Lyme Disease by Western Blot Sent to IGeneX Reference Lab Palo Alto California. Physicians may call 1-800- 832-3200 for results. |
|||||
Ordered by Dr. Robert Stowe
Collected November 6, 2015
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Thrombophilia Investigations | |||||
|---|---|---|---|---|---|
| Anti-Cardiolipin Antibodies | |||||
|
IgG
|
2.2 Clinically significant titres of anticardiolipin antibodies not detected. |
0-15
|
GPU
|
||
|
IgM
|
5.6 Clinically significant titres of anticardiolipin antibodies not detected. |
0-20.0
|
MPU
|
||
| Beta 2 Glycoprotein 1 | |||||
|
IgG
|
0.2 Clinically significant titres of Beta 2 Glycoprotein 1 not detected. |
0-20.0
|
SGU
|
||
|
IgM
|
1.2 Clinically significant titres of Beta 2 Glycoprotein 1 not detected. |
0-20.0
|
SMU
|
||
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Thyroid Function | |||||
|---|---|---|---|---|---|
|
Thyroperoxidase Ab
|
<10
|
<36
|
kIU/L
|
||
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Thrombophilia Investigations | |||||
|---|---|---|---|---|---|
| Dilute Russell’s Viper Venom Test | |||||
|
DRVV Ratio
|
1.1
|
0.8-1.2
|
|||
|
Pathologist Comments
|
|||||
| No evidence of a lupus anticoagulant. (Note: anticoagulant therapy can interfere with this test.) Reviewed by Dr.Lawrence Haley. (604-520-4318) |
|||||
| Referred Tests | |||||
| Beta 2 Glycoprotein 1 | |||||
|
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Beta 2 Glycoprotein 1 Ab IgG
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Beta 2 Glycoprotein 1 Ab IgM
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
| Thyroid Peroxidase | |||||
|
|
Referred to St Paul’s Hospital 1-877-747-2522
|
||||
| Cardiolipin Ab | |||||
|
Cardiolipin Ab Screen
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Cardiolipin Ab IgG
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Cardiolipin Ab IgM
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
| Paraneoplastic Profile | |||||
|
|
Referred to Mitogen Advanced Diag. Lab
|
||||
| Voltage Gated Potassium Channel Ab | |||||
|
|
Referred to Mitogen Advanced Diag. Lab
|
||||
| Anti-Streptolysin Titre | |||||
|
|
Referred to BC Centre for Disease Control 1-877-747-2522
|
||||
| Miscellaneous Test | |||||
|
|
Referred to BC Centre for Disease Control 1-877-747-2522
|
||||
Ordered by Dr. Robert Stowe
Collected March 11, 2016
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Thrombophilia Investigations | |||||
|---|---|---|---|---|---|
| Dilute Russell’s Viper Venom Test | |||||
|
DRVV Ratio
|
1.1
|
0.8-1.2
|
|||
|
Pathologist Comments
|
|||||
| No evidence of a lupus anticoagulant. (Note: anticoagulant therapy can interfere with this test.) Reviewed by Dr.Lawrence Haley. (604-520-4318) |
|||||
| Referred Tests | |||||
| Beta 2 Glycoprotein 1 | |||||
|
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Beta 2 Glycoprotein 1 Ab IgG
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Beta 2 Glycoprotein 1 Ab IgM
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
| Thyroid Peroxidase | |||||
|
|
Referred to St Paul’s Hospital 1-877-747-2522
|
||||
| Cardiolipin Ab | |||||
|
Cardiolipin Ab Screen
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Cardiolipin Ab IgG
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
|
Cardiolipin Ab IgM
|
Referred to Vancouver General Hospital 1-877-747-2522
|
||||
| Paraneoplastic Profile | |||||
|
|
Referred to Mitogen Advanced Diag. Lab
|
||||
| Voltage Gated Potassium Channel Ab | |||||
|
|
Referred to Mitogen Advanced Diag. Lab
|
||||
| Anti-Streptolysin Titre | |||||
|
|
Referred to BC Centre for Disease Control 1-877-747-2522
|
||||
| Miscellaneous Test | |||||
|
|
Referred to BC Centre for Disease Control 1-877-747-2522
|
||||
Ordered by Dr. Robert Stowe
Collected March 18, 2016
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Timed Urine Chemistry | |||||
|---|---|---|---|---|---|
| Urine Creatinine | |||||
|
Urine Creatinine 24h
|
10.1
|
5.0 – 16.0
|
mmol/d
|
||
| Please note low urine volume and/or urine creatinine. Query incomplete collection? Suggest repeat if clinically indicated. |
|||||
|
– Urine Volume
|
400
|
mL
|
|||
|
– Collection Duration
|
24.0
|
h
|
|||
|
– Collection Start Date
|
16/03/17
|
YY/MM/DD
|
|||
| Note: Sample collected during period specified. Reference interval and flags L or H are based on a 24h urine collection. |
|||||
| Urine 5HIAA | |||||
|
Urine 5HIAA 24h
|
10
|
< 50
|
umol/d
|
||
|
– Urine Volume
|
400
|
mL
|
|||
|
– Collection Duration
|
24.0
|
h
|
|||
|
– Collection Start Date
|
16/03/17
|
YY/MM/DD
|
|||
|
Note: Sample collected during period specified. Reviewed by Richard Cleve MD, FRCPC. (604-507-5000). |
|||||
| Urine VMA | |||||
|
Urine VMA 24h
|
22
|
< 38
|
umol/d
|
||
|
– Urine Volume
|
400
|
mL
|
|||
|
– Collection Duration
|
24.0
|
h
|
|||
|
– Collection Start Date
|
16/03/17
|
YY/MM/DD
|
|||
|
Note: Sample collected during period specified. Reviewed by Richard Cleve MD, FRCPC. (604-507-5000). |
|||||
| Urine Metanephrines Free | |||||
|
Urine Metanephrine Free 24h
|
0.135
|
< 0.200
|
umol/d
|
||
|
Urine Normetanephrine Free 24h
|
0.113
|
< 0.400
|
umol/d
|
||
|
Urine Volume
|
400
|
mL
|
|||
|
Collection Duration
|
24.0
|
h
|
|||
|
Collection Start Date
|
16/03/17
|
YY/MM/DD
|
|||
|
Note: Sample collected during period specified. Reviewed by Richard Cleve MD, FRCPC. (604-507-5000). |
|||||
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Timed Urine Chemistry | |||||
|---|---|---|---|---|---|
| Total Volume | |||||
| Urine volume: 400 | |||||
| Referred Tests | |||||
| Urine 5HIAA 24h | |||||
| Urine HIAA 24h Sent to BC Biomedical Laboratory. |
|||||
| Urine Metanephrines 24h | |||||
| Urine metanephrine 24h Sent to BC Biomedical Laboratory. |
|||||
| Urine VMA 24h | |||||
| Urine VMA 24h Sent to BC Biomedical Laboratory. |
|||||
Ordered by Dr. Emily Sung
Collected May 16, 2016
| Microbiology | |||||
|---|---|---|---|---|---|
| Chlamydia-N. gonorrhoeae Investigation | |||||
| Collection Date | 16/05/14 | ||||
| Site | Cervix | ||||
| Chlamydia trachomatis DNA (Probe) | Negative | ||||
| N. gonorrhoeae DNA (Probe) | Negative | ||||
| Genital Culture | |||||
| Collection Date | 16/05/14 | ||||
| Site | Vagina | ||||
| Gram Stain | Smear is EQUIVOCAL for Bacterial Vaginosis. For symptomatic women: one repeat smear may be warranted; repeatedly equivocal results may warrant a therapeutic trial. |
||||
| Yeast Culture | No yeast present | ||||
Ordered by Dr. Robert Stowe
Collected September 8, 2016
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| General Chemistry | |||||
|---|---|---|---|---|---|
|
Potassium
|
3.7
|
3.5-5.0
|
mmol/L
|
||
Ordered by Dr. Robert Stowe
Collected October 11, 2016
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| Hematology | |||||
|---|---|---|---|---|---|
|
WBC
|
5.8
|
4.0-10.0
|
10*9/L
|
||
|
RBC
|
4.62
|
3.50-5.00
|
10*12/L
|
||
|
Hemoglobin
|
134
|
115-155
|
g/L
|
||
|
Hematocrit
|
0.39
|
0.35-0.45
|
L/L
|
||
|
MCV
|
84
|
82-98
|
fl
|
||
|
MCH
|
29.0
|
27.5-33.5
|
pg
|
||
|
MCHC
|
344
|
300-370
|
g/L
|
||
|
RDW
|
14.1
|
11.5-14.5
|
%
|
||
|
Platelet Count
|
274
|
150-400
|
10*9/L
|
||
| Differential | |||||
|
Neutrophils
|
3.6
|
2.0-7.5
|
10*9/L
|
||
|
Lymphocytes
|
1.8
|
1.0-4.0
|
10*9/L
|
||
|
Monocytes
|
0.3
|
0.1-0.8
|
10*9/L
|
||
|
Eosinophils
|
0.1
|
0.0-0.7
|
10*9/L
|
||
|
Basophils
|
0.0
|
0.0-0.2
|
10*9/L
|
||
|
Granulocytes Immature
|
0.0
|
0.0-0.1
|
10*9/L
|
||
| General Chemistry | |||||
|
Glucose Fasting
|
4.7
|
3.3-5.5
|
mmol/L
|
||
|
Potassium
|
4.0
|
3.5-5.0
|
mmol/L
|
||
|
Lactate
|
1.2
|
0.7-2.1
|
mmol/L
|
||
| Muscle Enzymes | |||||
|
Creatine Kinase
|
45
|
<140
|
U/L
|
||
| Serum Proteins | |||||
|
C Reactive Protein (High Sensitivity)
|
2.0
|
mg/L
|
|||
|
Interpretation: Low Risk <1.0 mg/L Values >7.0 mg/L are significant for |
|||||
| Referred Tests | |||||
| Carnitine | |||||
| Carnitine Sent to BC Children’s Hospital. Physicians may call 1-877-747-2522 for results. |
|||||
| ECG | |||||
| Electrocardiogram Forwarded to the Cardiologist Interpretation will be sent directly to the ordering physician within three to five business days. |
|||||
| Phenylketonuria (PKU) | |||||
| PKU Sent to BC Children’s Hospital. Physicians may call 1-877-747-2522 for results. |
|||||
Ordered by Dr. Kourosh Eshafi
Collected December 17, 2017
| Microbiology | |||||
|---|---|---|---|---|---|
| Throat Culture | |||||
| Specimen received one day after collection. |
|||||
| Report Status | Final | ||||
| Organism 1 | 1) GROUP A STREPTOCOCCUS ISOLATED – Groups A, B, C and G streptococcal isolates are predictably susceptible to penicillin, amoxicillin and cephalosporins (e.g. cephalexin), therefore antimicrobial susceptibility testing is not routinely performed. Susceptibility to erythromycin and clindamycin is variable. |
||||
Ordered by Dr. Emily Sung
Collected September 18, 2019
| Cytology |
| CERVICAL CANCER SCREENING REPORT |
CERVICAL CANCER SCREENING REPORT SOURCE OF SPECIMEN(S) Cervix/ Endocervix -Brush and Spatula, 1 glass slide =========================================================================== INTERPRETATION Specimen satisfactory for evaluation. Endocervical / transformation zone component present. NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNANCY. RECOMMENDATION Please repeat cervical cancer screening in 36 months. The above recommendation is for average risk individuals. Please adjust if clinically indicated. ***Electronically Signed Out*** Cytotechnologist 58 This is a screening procedure with the potential for false negative and false positive results. If your patient has any clinically suspicious lesions, abnormal bleeding or other relevant symptoms, further evaluation is required, even if the screening test was normal. |
Ordered by Dr. Emily Sung
Collected October 7, 2019
| BCCA Screening Mammography Program |
I am pleased to inform you that your recent mammogram (breast |
Ordered by Dr. Emily Sung
Collected June 27, 2020
|
Flags
|
Results
|
Reference Range
|
Units
|
|||
|---|---|---|---|---|---|---|
| General Comments | |||||
|---|---|---|---|---|---|
| Hours After Meal | |||||
| hours pc: 14 | |||||
| Hematology | |||||
|
WBC
|
4.6
|
4.0-10.0
|
10*9/L
|
||
|
RBC
|
4.26
|
3.50-5.00
|
10*12/L
|
||
|
Hemoglobin
|
131
|
115-155
|
g/L
|
||
|
Hematocrit
|
0.38
|
0.35-0.45
|
L/L
|
||
|
MCV
|
89
|
82-98
|
fl
|
||
|
MCH
|
30.8
|
27.5-33.5
|
pg
|
||
|
MCHC
|
346
|
300-370
|
g/L
|
||
|
RDW
|
12.7
|
11.5-14.5
|
%
|
||
|
Platelet Count
|
224
|
150-400
|
10*9/L
|
||
| Differential | |||||
|
Neutrophils
|
2.6
|
2.0-7.5
|
10*9/L
|
||
|
Lymphocytes
|
1.4
|
1.0-4.0
|
10*9/L
|
||
|
Monocytes
|
0.4
|
0.1-0.8
|
10*9/L
|
||
|
Eosinophils
|
0.1
|
0.0-0.7
|
10*9/L
|
||
|
Basophils
|
0.0
|
0.0-0.2
|
10*9/L
|
||
|
Granulocytes Immature
|
0.0
|
0.0-0.1
|
10*9/L
|
||
| Biochemical Investigation of Anemias and Iron Overload | |||||
|
Vitamin B12
|
271
|
153-655
|
pmol/L
|
||
|
> 220 pmol/L Normal, New interpretation effective Feb. 5, 2020 |
|||||
|
Ferritin
|
28
|
15-247
|
ug/L
|
||
|
Adults >18 y: See BC guideline for Iron Deficiency |
|||||
| Urinalysis | |||||
| Urine Microscopic | |||||
|
WBC
|
1-5
|
0-5
|
/HPF
|
||
|
RBC
|
1-2
|
0-2
|
/HPF
|
||
| RBC reference interval revised to harmonize with clinical guidelines. |
|||||
|
Non-Squamous Epithelial Cells
|
1-5
|
0-5
|
/HPF
|
||
|
|
Microscopic rbcs, wbcs, and casts are A repeat review of original microscopy |
||||
| General Chemistry | |||||
|
Glucose Fasting
|
4.8
|
3.3-5.5
|
mmol/L
|
||
| Hemoglobin A1C | |||||
|
Hemoglobin A1C
|
5.4
|
4.5-6.0
|
%
|
||
| Therapeutic target for most adults with type 1 or type 2 diabetes is <=7.0%. In the frail elderly and patients who are prone to hypoglycemia, target is <=8.5%. A1c >=6.5% meets the criterion for type 2 diabetes mellitus in adults. See 2018 Diabetes Canada guidelines. |
|||||
|
Sodium
|
140
|
135-145
|
mmol/L
|
||
|
Potassium
|
4.3
|
3.5-5.0
|
mmol/L
|
||
|
Calcium
|
2.18
|
2.10-2.60
|
mmol/L
|
||
|
Calcium Ionized
|
1.22
|
1.12-1.31
|
mmol/L
|
||
|
Alkaline Phosphatase
|
64
|
35-120
|
U/L
|
||
|
Gamma GT
|
6
|
<31
|
U/L
|
||
|
Alanine Aminotransferase
|
10
|
<36
|
U/L
|
||
| Muscle Enzymes | |||||
|
Creatine Kinase
|
89
|
<140
|
U/L
|
||
| Cardiac Investigation | |||||
|
Troponin T (High Sensitivity)
|
<6
|
<14
|
ng/L
|
||
|
Performed on Roche e602. Normal TnT level indicates a |
|||||
| Lipids | |||||
|
Cholesterol
|
2.90
|
2.00-5.19
|
mmol/L
|
||
|
LDL Cholesterol
|
A
|
0.95
|
1.50-3.40
|
mmol/L
|
|
| The optimal LDL cholesterol level for intermediate and high risk individuals is <= 2.00 mmol/L. If triglycerides are => 1.50 mmol/L, consider monitoring of alternate lipid targets non HDL-cholest- erol or apoB. For low risk individuals with LDL cholesterol => 5.00 mmol/L, target reduction of LDL cholesterol => 50 percent. See Can J Cardiol 2013 vol 29 pgs 151 to 167. |
|||||
|
HDL Cholesterol
|
1.83
|
>1.19
|
mmol/L
|
||
|
Chol/HDL (Risk Ratio)
|
1.58
|
<4.4
|
|||
|
Non HDL Cholesterol
|
1.07
|
mmol/L
|
|||
| Non HDL-cholesterol is calculated from total cholesterol and HDL-C and is not affected by the fasting status of the patient. The optimal non HDL-cholesterol level for intermediate and high risk individuals is <= 2.60 mmol/L. See Can J Cardiol 2013 vol 29 pgs 151 to 167. |
|||||
|
Triglycerides
|
0.27
|
<2.21
|
mmol/L
|
||
| Random Urine Chemistry | |||||
| Urine Creatinine | |||||
|
Urine Creatinine
|
11.11
|
mmol/L
|
|||
| No reference range has been established for this test. |
|||||
| Urine Protein Electrophoresis | |||||
|
Urine Protein
|
0.06
|
g/L
|
|||
| No reference range has been established for this test. |
|||||
| Urine Protein Electrophoresis | |||||
|
Urine Electrophoresis
|
Virtually no protein seen by
electrophoresis, at x100 concentration. Interpreted by Ramesh Saeedi MD, PhD, FRCPC |
||||
| Urine (Micro)albumin | |||||
|
ACR (Microalbumin/Creatinine Ratio)
|
<1.0
|
<2.8
|
mg/mmol
|
||
| Note: Reference interval for albumin/creatinine ratio as per BCMA/MSC guidelines. |
|||||
| Thyroid Function | |||||
|
TSH
|
1.36
|
0.32-5.04
|
mU/L
|
||
| Gestational reference intervals: 1st Trimester 0.10-3.50 mU/L 2nd Trimester 0.30-3.50 mU/L 3rd Trimester 0.45-4.00 mU/L |
|||||
| Serum Proteins | |||||
| Protein Electrophoresis | |||||
|
Total Protein
|
66
|
60-80
|
g/L
|
||
| Protein Electrophoresis | |||||
|
Albumin
|
38.7
|
35.0-50.0
|
g/L
|
||
|
Alpha 1 Globulin
|
2.6
|
2.0-4.0
|
g/L
|
||
|
Alpha 2 Globulin
|
5.9
|
5.0-9.0
|
g/L
|
||
|
Beta 1 Globulin
|
4.4
|
3.0-6.0
|
g/L
|
||
|
Beta 2 Globulin
|
3.8
|
2.0-5.0
|
g/L
|
||
|
Gamma Globulin
|
10.6
|
7.0-14.0
|
g/L
|
||
|
Pattern
|
No paraprotein band is seen on
electrophoresis. Interpreted by Ramesh Saeedi MD, PhD, FRCPC |
||||
|
C Reactive Protein (High Sensitivity)
|
1.4
|
<4.8
|
mg/L
|
||
| Interpretation: This high sensitivity CRP method is sensitive to 0.3 mg/L and is suitable for coronary artery disease assess- ment and detection of active inflamma- tion. |
|||||
| Microbiology | |||||
| Urine Culture | |||||
| Comment | Urine culture not performed as urinalysis criteria not met according to MSC protocol. |
||||
| Virology | |||||
| Hepatitis Serology | |||||
| Hep A Antibody IgM | Non-Reactive | ||||
| No evidence of active acute Hepatitis A infection. |
|||||
| Hep B Surface Antigen(HBsAg) | Non-Reactive | ||||
| Initially non-reactive. No confirmatory neutralization assay required. No evidence of active Hepatitis B infection. |
|||||
| Referred Tests | |||||
| ECG | |||||
| Electrocardiogram Forwarded to the Cardiologist Interpretation will be sent directly to the ordering physician within three to five business days. |
|||||
| Hep C Ab | |||||
| Hepatitis C Sent to BC Centre for Disease Control (Prov Lab). Physicians may call 1-877-747-2522 (1-877-PHSALAB) for results. |
|||||
Ordered by Dr. Emily Sung
Collected January 5, 2021
| BCCA Screening Mammography Program |
We are pleased to let you know that the result of your recent mammogram |
Ordered by Dr. Emily Sung
Collected December 5, 2022
| Cytology |
| CERVICAL CANCER SCREENING REPORT |
CERVICAL CANCER SCREENING REPORT
SOURCE OF SPECIMEN(S) This is a screening procedure with the potential for false negative and false positive results. If your patient has any clinically suspicious lesions, abnormal bleeding or other relevant symptoms, further evaluation is required, even if the screening test was normal. |
Ordered by Dr. Robert Stowe
Collected March 23, 2023
| Virology | |||||
|---|---|---|---|---|---|
| Herpes Simplex+Varicella Zoster | |||||
| Referred to BC Centre for Disease Control. Physicians may call 1-877-747-2522 for more information. | |||||
| Referred Tests | |||||
|---|---|---|---|---|---|
| Herpes/Varicella (PCR/NAAT) | |||||
| HERPES/VARICELLA NAT PAINFUL LESION VZV VIRUS ISOLATION COLLECTED 23-MAR-2023 Sent to BCCDC PHL for testing. For further information on testing or con- sultation see http://www.elabhandbook. info/phsa/ |
|||||
The Early Stages
Click to read more...
The First Episode
Click to read more...
Royal Columbian Hospital
Click to read more...
Searching for a Diagnosis
Click to read more...
Living with Episodes
Click to read more...